ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 172 filers reported holding ARRAY BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $176,000 | +58.6% | 11,600 | -12.8% | 0.05% | +193.8% |
| Q2 2017 | $111,000 | -34.3% | 13,300 | -46.8% | 0.02% | -66.0% |
| Q3 2016 | $169,000 | +37.4% | 25,000 | -14.1% | 0.05% | +9.3% |
| Q4 2015 | $123,000 | -82.4% | 29,100 | -69.4% | 0.04% | -70.3% |
| Q1 2015 | $700,000 | – | 95,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |